T Nebout

847 total citations
13 papers, 671 citations indexed

About

T Nebout is a scholar working on Cardiology and Cardiovascular Medicine, Nephrology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, T Nebout has authored 13 papers receiving a total of 671 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Cardiology and Cardiovascular Medicine, 3 papers in Nephrology and 3 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in T Nebout's work include Drug-Induced Hepatotoxicity and Protection (2 papers), Renal Diseases and Glomerulopathies (2 papers) and Receptor Mechanisms and Signaling (2 papers). T Nebout is often cited by papers focused on Drug-Induced Hepatotoxicity and Protection (2 papers), Renal Diseases and Glomerulopathies (2 papers) and Receptor Mechanisms and Signaling (2 papers). T Nebout collaborates with scholars based in France, Sweden and United Kingdom. T Nebout's co-authors include Börje Darpö, Philip T. Sager, G Lagrue, Georges Houin, Felix Brunner, Jean-Claude Ansquer, J. Laurent, G. Laurent, J Bedrossian and A Duboust and has published in prestigious journals such as Transplantation, British Journal of Clinical Pharmacology and The Journal of Clinical Pharmacology.

In The Last Decade

T Nebout

12 papers receiving 630 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
T Nebout France 6 432 265 70 54 49 13 671
Sarah Batson United Kingdom 14 222 0.5× 114 0.4× 19 0.3× 22 0.4× 75 1.5× 30 666
Marianne Keisu Sweden 13 116 0.3× 52 0.2× 27 0.4× 55 1.0× 90 1.8× 18 613
Matthew J. Kolek United States 15 356 0.8× 133 0.5× 11 0.2× 37 0.7× 50 1.0× 32 854
Lucette Doessegger Switzerland 8 62 0.1× 108 0.4× 59 0.8× 35 0.6× 44 0.9× 12 340
Nihal El Rouby United States 12 83 0.2× 133 0.5× 17 0.2× 48 0.9× 51 1.0× 24 617
Ju‐Hee Lee South Korea 15 355 0.8× 256 1.0× 11 0.2× 36 0.7× 109 2.2× 61 855
Joakim Nyberg Sweden 13 44 0.1× 80 0.3× 85 1.2× 92 1.7× 39 0.8× 45 570
Bénédicte Bénéteau‐Burnat France 13 156 0.4× 157 0.6× 13 0.2× 52 1.0× 32 0.7× 28 550
Yiel‐Hea Seo South Korea 12 230 0.5× 107 0.4× 13 0.2× 39 0.7× 53 1.1× 35 742
Timothy C. Hardman United Kingdom 14 54 0.1× 155 0.6× 23 0.3× 20 0.4× 33 0.7× 60 621

Countries citing papers authored by T Nebout

Since Specialization
Citations

This map shows the geographic impact of T Nebout's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T Nebout with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T Nebout more than expected).

Fields of papers citing papers by T Nebout

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T Nebout. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T Nebout. The network helps show where T Nebout may publish in the future.

Co-authorship network of co-authors of T Nebout

This figure shows the co-authorship network connecting the top 25 collaborators of T Nebout. A scholar is included among the top collaborators of T Nebout based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T Nebout. T Nebout is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
2.
Sager, Philip T., T Nebout, & Börje Darpö. (2005). ICH E14: A New Regulatory Guidance on the Clinical Evaluation of QT/QTc Internal Prolongation and Proarrhythmic Potential for Non-antiarrhythmic Drugs. Drug Information Journal. 39(4). 387–394. 332 indexed citations
3.
Nebout, T, et al.. (1990). [Zidovudine. The current status of its evaluation].. PubMed. 44(6). 393–9. 2 indexed citations
4.
Bourin, Michel, J. N. Colin, M. F. Kergueris, et al.. (1988). Assessment by antipyrine test of bupropion enzymic induction in elderly depressed patients. Human Psychopharmacology Clinical and Experimental. 3(4). 281–284. 1 indexed citations
5.
6.
Cabané, J., François Boué, P Godeau, et al.. (1985). Essai de traitement du phénomène de raynaud sévère par la prostacycline (PGI2). La Revue de Médecine Interne. 6(5). 581–589. 2 indexed citations
7.
Lebrault, C., et al.. (1984). Effet myorelaxant de l'atracurium chez les patients insuffisants rénaux chroniques. Annales Françaises d Anesthésie et de Réanimation. 3(4). 273–276. 2 indexed citations
8.
Lagrue, G, et al.. (1984). Serum IgE in Primary Glomerular Diseases. ˜The œNephron journals/Nephron journals. 36(1). 5–9. 22 indexed citations
9.
Houin, Georges, et al.. (1983). The effects of chronic renal insufficiency on the pharmacokinetics of doxycycline in man.. British Journal of Clinical Pharmacology. 16(3). 245–252. 24 indexed citations
10.
Farcet, Jean Pierre, et al.. (1982). A hypereosinophilic syndrome with retinal arteritis and tuberculosis.. PubMed. 142(3). 625–7. 10 indexed citations
11.
Chopin, D, et al.. (1981). [Scintigraphy with technetium dimercaptosuccinic acid (99 m TC DMSA). Contribution to the functional assessment of individual kidneys (author's transl)].. PubMed. 10(18). 1475–8. 1 indexed citations
12.
Lepage, V., J C Gluckman, J Bedrossian, et al.. (1978). ANTI-B CELL LYMPHOCYTOTOXIC ANTIBODIES IN KIDNEY TRANSPLANT RECIPIENTS. Transplantation. 25(5). 255–258. 13 indexed citations
13.
Nebout, T, Daniel Dhumeaux, & P. Berthelot. (1974). [Jaundice and rifampicin. Critical study].. PubMed. 3(12). 733–6. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sarah Batson Breakdown of academic impact, for papers by Marianne Keisu Breakdown of academic impact, for papers by Matthew J. Kolek Breakdown of academic impact, for papers by Lucette Doessegger Breakdown of academic impact, for papers by Nihal El Rouby Breakdown of academic impact, for papers by Ju‐Hee Lee Breakdown of academic impact, for papers by Joakim Nyberg Breakdown of academic impact, for papers by Bénédicte Bénéteau‐Burnat Breakdown of academic impact, for papers by Yiel‐Hea Seo Breakdown of academic impact, for papers by Timothy C. Hardman
Rankless by CCL
2026